Comments
Loading...

Inhibikase Therapeutics

IKTNASDAQ
Logo brought to you by Benzinga Data
$1.40
0.010.72%
At Close: -
$1.46
0.064.29%
After Hours: Aug 23, 7:58 AM EDT
15 minutes delayed

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
May
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Inhibikase Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase i...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IKT
ERNA

FAQ

Q

How do I buy Inhibikase Therapeutics (IKT) stock?

A

You can purchase shares of Inhibikase Therapeutics (NASDAQ:IKT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Inhibikase Therapeutics (IKT) competitors?

Q

What is the forecast, or price target, for Inhibikase Therapeutics (IKT) stock?

A

Inhibikase Therapeutics has a consensus price target of $15.00.

Q

What is the current price for Inhibikase Therapeutics (IKT)?

A

The stock price for Inhibikase Therapeutics (NASDAQ: IKT) is $1.46 last updated August 23, 2024 at 7:58 AM EDT.

Q

Does Inhibikase Therapeutics (IKT) pay a dividend?

A

There are no upcoming dividends for Inhibikase Therapeutics.

Q

When is Inhibikase Therapeutics (NASDAQ:IKT) reporting earnings?

A

Inhibikase Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Q

Is Inhibikase Therapeutics (IKT) going to split?

A

There is no upcoming split for Inhibikase Therapeutics.

Q

What sector and industry does Inhibikase Therapeutics (IKT) operate in?

A

Inhibikase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch